Dr. Biswendu- Wellness
- February 22, 2026
- 37 views
Ozempic and Mounjaro Set to Disrupt India’s Food and Alcohol Markets
Patent expiry, generics and global consumption shifts could push Ozempic and Mounjaro into India’s mass market, reshaping obesity care and consumer spending Ozempic India patent expiry, Mounjaro India launch, GLP-1…
Dr. Biswendu- Wellness
- December 3, 2025
- 94 views
WHO’s Obesity Guidelines: Benefits, Risks, and Long-Term Use of GLP-1 Drugs
The World Health Organization now recognizes obesity as a chronic disease and recommends GLP-1 weight loss drugs such as Ozempic and Mounjaro as part of long-term treatment. Until now, the…
You May Missed
Parliament Budget Session Disruption Over Middle East Crisis Debate
Dr. Biswendu- March 9, 2026
- 3 views
India T20 World Cup 2026 Victory: Men in Blue Script Historic Title Defence
Digital Team- March 8, 2026
- 3 views
Israel–Iran War Day 6: US Strike, Global Tensions Rise
Digital Team- March 5, 2026
- 5 views







